Cone Health’s GeneConnect Tops 12,000 Enrollees; Graham Woman Credits Early BRCA2 Detection

Cone Health announced that its GeneConnect community research and screening program has enrolled more than 12,000 participants, and a Graham mother, Tanya Gozick‑Broome, learned through that screening that she carries a BRCA2 mutation, giving her the opportunity to take proactive steps before cancer developed.

On March 4, 2026, Cone Health released the enrollment milestone for GeneConnect and described the program as expanding access to no-cost genetic screening while advancing precision medicine in North Carolina. Cone Health framed GeneConnect as a community research and screening program intended to broaden preventive care across hospitals in the state.

A LinkedIn post excerpt tied to the announcement reiterated the scale: "More than 12,000 people have enrolled in Cone Health's GeneConnect program, expanding access to no-cost genetic screening and advancing precision medicine in North Carolina." That post included the line "Early detection can change, and even save, lives." and used the hashtags #NCHospitals #EarlyDetection #NCHealthcare #NCHealth.

The announcement specifically highlighted the local impact in Alamance County by naming Graham resident Tanya Gozick‑Broome as an example of the program's reach. For one Graham mother, screening revealed a BRCA2 mutation, giving her the opportunity to take proactive steps before cancer developed, the LinkedIn excerpt said. The Cone Health materials do not list the exact follow-up steps Gozick‑Broome took, nor do they provide a county-by-county breakdown of the more than 12,000 enrollees.

Cone Health’s messaging positions GeneConnect as a no-cost option for genetic screening, but the announcement and social post excerpts do not disclose program start date, the full panel of genes screened, or demographic details for participants. The materials do not include direct quotes from Cone Health executives or from Tanya Gozick‑Broome, beyond the third-person account of her BRCA2 result in the LinkedIn text.

Local health systems and clinicians in North Carolina are being presented as prioritizing prevention, early detection and personalized care through initiatives like GeneConnect, according to the announcement and social copy. The LinkedIn excerpt also included a "Learn more:" prompt, indicating additional information was available through the original post or accompanying materials.

With more than 12,000 enrollees reported, Cone Health’s GeneConnect has reached a scale the announcement presents as significant for statewide precision medicine efforts; for Graham residents like Tanya Gozick‑Broome, the program's screening result translated into a concrete opportunity to act before cancer developed.